Your browser doesn't support javascript.
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
Mihai, Carina; Dobrota, Rucsandra; Schröder, Maria; Garaiman, Alexandru; Jordan, Suzana; Becker, Mike Oliver; Maurer, Britta; Distler, Oliver.
  • Mihai C; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Dobrota R; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Schröder M; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Garaiman A; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Jordan S; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Becker MO; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Maurer B; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Distler O; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland oliver.distler@usz.ch.
Ann Rheum Dis ; 79(5): 668-669, 2020 05.
Article in English | MEDLINE | ID: covidwho-30814

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Scleroderma, Systemic / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus Type of study: Case report Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-217442

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Scleroderma, Systemic / Coronavirus Infections / Antibodies, Monoclonal, Humanized / Betacoronavirus Type of study: Case report Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-217442